Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tracon Pharmaceuticals Inc (TCON)

Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Tracon: Q1 Earnings Snapshot

Tracon: Q1 Earnings Snapshot

TCON : 0.8499 (-15.01%)
Tracon: Q4 Earnings Snapshot

Tracon: Q4 Earnings Snapshot

TCON : 0.8499 (-15.01%)
Tracon: Q3 Earnings Snapshot

Tracon: Q3 Earnings Snapshot

TCON : 0.8499 (-15.01%)
Tracon: Q2 Earnings Snapshot

Tracon: Q2 Earnings Snapshot

TCON : 0.8499 (-15.01%)
Tracon: Q1 Earnings Snapshot

Tracon: Q1 Earnings Snapshot

TCON : 0.8499 (-15.01%)
Tracon: Q4 Earnings Snapshot

Tracon: Q4 Earnings Snapshot

TCON : 0.8499 (-15.01%)
Tracon: Q3 Earnings Snapshot

Tracon: Q3 Earnings Snapshot

TCON : 0.8499 (-15.01%)
US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that the U.S. Food and Drug Administration (FDA) has approved the...

TCON : 0.8499 (-15.01%)
TRACON Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a...

TCON : 0.8499 (-15.01%)
TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial

Trial to Continue as Planned...

TCON : 0.8499 (-15.01%)

Barchart Exclusives

Are These 3 Casino Stocks a Good Buy Now?
Analysts rate all three casino stocks a “strong buy," and expect them to rally about 30% to 45%. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar